Rite Aid Corp.
Latest From Rite Aid Corp.
The head of the UK’s health technology assessment body NICE is stepping down, while the country’s medicines agency, the MHRA, will have an interim chief in the run-up to the UK’s planned Brexit from the European Union on 31 October.
Despite current risks in an uncertain legal environment, the opportunity for CBD-infused cosmetics at a time of rocketing interest in all things cannabis is proving too great for many companies to resist.
FDA’s GMP final rule set uniform standards to ensure quality throughout manufacturing, packaging, labeling and holding of supplements, but Supplement Safety and Compliance Initiative says manufacturing practices continue to vary widely across the industry and the agency cannot inspect every facility. “FDA can’t solve all our problems. I don’t know if FDA knows the number of facilities it needs to inspect to ensure consumer confidence," says Daniel Fabricant, president of SSCI member NPA.
Rite Aid discontinues “#1 doctor recommended” and similar claims promoting OTC drug, dietary supplement and other health and wellness brands when National Advertising Division reminds firm that retailers cannot rely on suppliers' assertion of accuracy about claims but must have their own substantiation.
- OTC, Consumer
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Rite Aid Corp.
- Senior Management
Heyward Donigan, CEO
Darren W Karst, Senior EVP, CFO, & Chief Admin. Officer
Frank G Vitrano, Chief Strategic Bus. Dev. Officer
- Contact Info
Rite Aid Corp.
Phone: (717) 761-2633
30 Hunter Lane
Camp Hill, PA 17011
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.